ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Mettl3-Mediated m6A Modification Represents a Novel Therapeutic Target for FSGS.

Fubin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.